Other Species / Isoforms
  14-3-3 sigma (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MERAsLIQkAkL
Upstream
0 1
Treatment
  • nocodazole
14-3-3 sigma (human) ___MERAsLIQkAkL S5-p
14-3-3 sigma iso2 (human) ___MERASLIQKAKL S5
14-3-3 sigma (mouse) ___MERASLIQKAkL S5
K9-ub
ERAsLIQkAkLAEQA
0 1
14-3-3 sigma (human) ERAsLIQkAkLAEQA K9-ub
14-3-3 sigma iso2 (human) ERASLIQKAKLAEQA K9
14-3-3 sigma (mouse) ERASLIQKAkLAEQA K9
K11-ub
AsLIQkAkLAEQAER
0 38
14-3-3 sigma (human) AsLIQkAkLAEQAER K11-ub
14-3-3 sigma iso2 (human) ASLIQKAKLAEQAER K11
14-3-3 sigma (mouse) ASLIQKAkLAEQAER K11-ub
Y19-p
LAEQAERyEDMAAFM
1 2
14-3-3 sigma (human) LAEQAERyEDMAAFM Y19-p
14-3-3 sigma iso2 (human) LAEQAERYEDMAAFM Y19
14-3-3 sigma (mouse) LAEQAERyEDMAAFM Y19-p
G28
DMAAFMKGAVEkGEE
1 1
14-3-3 sigma (human) DMAAFMKGAVEkGEE G28
14-3-3 sigma iso2 (human) DMAAFMKGAVEKGEE G28
14-3-3 sigma (mouse) DMAAFMKsAVEKGEE S28-p
K32-ac
FMKGAVEkGEELSCE
0 1
14-3-3 sigma (human) FMKGAVEkGEELSCE K32-ac
14-3-3 sigma iso2 (human) FMKGAVEKGEELSCE K32
14-3-3 sigma (mouse) FMKsAVEKGEELSCE K32
K32-ub
FMKGAVEkGEELSCE
0 1
14-3-3 sigma (human) FMKGAVEkGEELSCE K32-ub
14-3-3 sigma iso2 (human) FMKGAVEKGEELSCE K32
14-3-3 sigma (mouse) FMKsAVEKGEELSCE K32
S45-p
CEERNLLsVAykNVV
0 29
14-3-3 sigma (human) CEERNLLsVAykNVV S45-p
14-3-3 sigma iso2 (human) CEERNLLSVAYKNVV S45
14-3-3 sigma (mouse) CEERNLLsVAyKNVV S45-p
Y48-p
RNLLsVAykNVVGGQ
0 12
14-3-3 sigma (human) RNLLsVAykNVVGGQ Y48-p
14-3-3 sigma iso2 (human) RNLLSVAYKNVVGGQ Y48
14-3-3 sigma (mouse) RNLLsVAyKNVVGGQ Y48-p
K49-ac
NLLsVAykNVVGGQR
0 14
14-3-3 sigma (human) NLLsVAykNVVGGQR K49-ac
14-3-3 sigma iso2 (human) NLLSVAYKNVVGGQR K49
14-3-3 sigma (mouse) NLLsVAyKNVVGGQR K49
K49-ub
NLLsVAykNVVGGQR
0 12
14-3-3 sigma (human) NLLsVAykNVVGGQR K49-ub
14-3-3 sigma iso2 (human) NLLSVAYKNVVGGQR K49
14-3-3 sigma (mouse) NLLsVAyKNVVGGQR K49
S63-p
RAAWRVLssIEQksN
0 3
14-3-3 sigma (human) RAAWRVLssIEQksN S63-p
14-3-3 sigma iso2 (human) RAAWRVLSSIEQKSN S63
14-3-3 sigma (mouse) RAAWRVLssIEQKsN S63-p
S64-p
AAWRVLssIEQksNE
0 4
14-3-3 sigma (human) AAWRVLssIEQksNE S64-p
14-3-3 sigma iso2 (human) AAWRVLSSIEQKSNE S64
14-3-3 sigma (mouse) AAWRVLssIEQKsNE S64-p
K68-ub
VLssIEQksNEEGsE
0 2
14-3-3 sigma (human) VLssIEQksNEEGsE K68-ub
14-3-3 sigma iso2 (human) VLSSIEQKSNEEGSE K68
14-3-3 sigma (mouse) VLssIEQKsNEEGsE K68
S69-p
LssIEQksNEEGsEE
Upstream
Downstream
2 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
  • transcription, induced
Regulatory protein:
  • CK2A1 (human)
Treatment
  • TGF-beta
14-3-3 sigma (human) LssIEQksNEEGsEE S69-p
14-3-3 sigma iso2 (human) LSSIEQKSNEEGSEE S69
14-3-3 sigma (mouse) LssIEQKsNEEGsEE S69-p
S74-p
QksNEEGsEEkGPEV
Upstream
Downstream
2 7
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
  • transcription, induced
Regulatory protein:
  • CK2A1 (human)
Treatment
  • TGF-beta
14-3-3 sigma (human) QksNEEGsEEkGPEV S74-p
14-3-3 sigma iso2 (human) QKSNEEGSEEKGPEV S74
14-3-3 sigma (mouse) QKsNEEGsEEKGPEV S74-p
K77-ub
NEEGsEEkGPEVREY
0 2
14-3-3 sigma (human) NEEGsEEkGPEVREY K77-ub
14-3-3 sigma iso2 (human) NEEGSEEKGPEVREY K77
14-3-3 sigma (mouse) NEEGsEEKGPEVKEY K77
K87-ub
EVREYREkVETELQG
0 1
14-3-3 sigma (human) EVREYREkVETELQG K87-ub
14-3-3 sigma iso2 (human) under review -
14-3-3 sigma (mouse) EVKEYREKVEtELRG K87
T90
EYREkVETELQGVCD
1 1
14-3-3 sigma (human) EYREkVETELQGVCD T90
14-3-3 sigma iso2 (human) gap -
14-3-3 sigma (mouse) EYREKVEtELRGVCD T90-p
T98
ELQGVCDTVLGLLDS
1 1
14-3-3 sigma (human) ELQGVCDTVLGLLDS T98
14-3-3 sigma iso2 (human) gap -
14-3-3 sigma (mouse) ELRGVCDtVLGLLDS T98-p
K109-ub
LLDSHLIkEAGDAEs
0 3
14-3-3 sigma (human) LLDSHLIkEAGDAEs K109-ub
14-3-3 sigma iso2 (human) gap -
14-3-3 sigma (mouse) LLDSHLIkGAGDAEs K109-ub
S116-p
kEAGDAEsRVFYLkM
1 2
14-3-3 sigma (human) kEAGDAEsRVFYLkM S116-p
14-3-3 sigma iso2 (human) gap -
14-3-3 sigma (mouse) kGAGDAEsRVFYLkM S116-p
K122-ac
EsRVFYLkMkGDYyR
Upstream
0 11
Treatment
  • vorinostat
14-3-3 sigma (human) EsRVFYLkMkGDYyR K122-ac
14-3-3 sigma iso2 (human) EYRVFYLKMKGDYYR K90
14-3-3 sigma (mouse) EsRVFYLkMkGDYyR K122-ac
K122-ub
EsRVFYLkMkGDYyR
0 73
14-3-3 sigma (human) EsRVFYLkMkGDYyR K122-ub
14-3-3 sigma iso2 (human) EYRVFYLKMKGDYYR K90
14-3-3 sigma (mouse) EsRVFYLkMkGDYyR K122-ub
K124-ub
RVFYLkMkGDYyRyL
0 9
14-3-3 sigma (human) RVFYLkMkGDYyRyL K124-ub
14-3-3 sigma iso2 (human) RVFYLKMKGDYYRYL K92
14-3-3 sigma (mouse) RVFYLkMkGDYyRYL K124-ub
Y128-p
LkMkGDYyRyLAEVA
0 35
14-3-3 sigma (human) LkMkGDYyRyLAEVA Y128-p
14-3-3 sigma iso2 (human) LKMKGDYYRYLAEVA Y96
14-3-3 sigma (mouse) LkMkGDYyRYLAEVA Y128-p
Y130-p
MkGDYyRyLAEVAtG
1 0
14-3-3 sigma (human) MkGDYyRyLAEVAtG Y130-p
14-3-3 sigma iso2 (human) MKGDYYRYLAEVATG Y98
14-3-3 sigma (mouse) MkGDYyRYLAEVAtG Y130
T136-p
RyLAEVAtGDDkkRI
0 4
14-3-3 sigma (human) RyLAEVAtGDDkkRI T136-p
14-3-3 sigma iso2 (human) RYLAEVATGDDKKRI T104
14-3-3 sigma (mouse) RYLAEVAtGDDKKRI T136-p
K140-ub
EVAtGDDkkRIIDsA
0 1
14-3-3 sigma (human) EVAtGDDkkRIIDsA K140-ub
14-3-3 sigma iso2 (human) EVATGDDKKRIIDSA K108
14-3-3 sigma (mouse) EVAtGDDKKRIIDSA K140
K141-ac
VAtGDDkkRIIDsAR
0 1
14-3-3 sigma (human) VAtGDDkkRIIDsAR K141-ac
14-3-3 sigma iso2 (human) VATGDDKKRIIDSAR K109
14-3-3 sigma (mouse) VAtGDDKKRIIDSAR K141
S146-p
DkkRIIDsARsAyQE
0 1
14-3-3 sigma (human) DkkRIIDsARsAyQE S146-p
14-3-3 sigma iso2 (human) DKKRIIDSARSAYQE S114
14-3-3 sigma (mouse) DKKRIIDSARSAYQE S146
S149-p
RIIDsARsAyQEAMD
0 1
14-3-3 sigma (human) RIIDsARsAyQEAMD S149-p
14-3-3 sigma iso2 (human) RIIDSARSAYQEAMD S117
14-3-3 sigma (mouse) RIIDSARSAYQEAMD S149
Y151-p
IDsARsAyQEAMDIS
0 2
14-3-3 sigma (human) IDsARsAyQEAMDIS Y151-p
14-3-3 sigma iso2 (human) IDSARSAYQEAMDIS Y119
14-3-3 sigma (mouse) IDSARSAYQEAMDIS Y151
K159-ac
QEAMDISkkEMPPTN
0 4
14-3-3 sigma (human) QEAMDISkkEMPPTN K159-ac
14-3-3 sigma iso2 (human) QEAMDISKKEMPPTN K127
14-3-3 sigma (mouse) QEAMDISKKEMPPTN K159
K160-ub
EAMDISkkEMPPTNP
0 1
14-3-3 sigma (human) EAMDISkkEMPPTNP K160-ub
14-3-3 sigma iso2 (human) EAMDISKKEMPPTNP K128
14-3-3 sigma (mouse) EAMDISKKEMPPTNP K160
S186-p
FHYEIANsPEEAISL
Upstream
Downstream
5 0
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, induced
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (human)
Treatment
  • anisomycin
  • SP600125
14-3-3 sigma (human) FHYEIANsPEEAISL S186-p
14-3-3 sigma iso2 (human) FHYEIANSPEEAISL S154
14-3-3 sigma (mouse) FHYEIANsPEEAISL S186-p
T207-p
EAMADLHtLsEDSYk
0 1
14-3-3 sigma (human) EAMADLHtLsEDSYk T207-p
14-3-3 sigma iso2 (human) EAMADLHTLSEDSYK T175
14-3-3 sigma (mouse) EAMADLHTLSEDSYK T207
S209-p
MADLHtLsEDSYkDs
0 2
14-3-3 sigma (human) MADLHtLsEDSYkDs S209-p
14-3-3 sigma iso2 (human) MADLHTLSEDSYKDS S177
14-3-3 sigma (mouse) MADLHTLSEDSYKDs S209
K214-ac
tLsEDSYkDsTLIMQ
0 1
14-3-3 sigma (human) tLsEDSYkDsTLIMQ K214-ac
14-3-3 sigma iso2 (human) TLSEDSYKDSTLIMQ K182
14-3-3 sigma (mouse) TLSEDSYKDsTLIMQ K214
S216-p
sEDSYkDsTLIMQLL
0 2
14-3-3 sigma (human) sEDSYkDsTLIMQLL S216-p
14-3-3 sigma iso2 (human) SEDSYKDSTLIMQLL S184
14-3-3 sigma (mouse) SEDSYKDsTLIMQLL S216-p
S248-p
EAPQEPQs_______
Upstream
0 8
Treatment
  • nocodazole
14-3-3 sigma (human) EAPQEPQs_______ S248-p
14-3-3 sigma iso2 (human) EAPQEPQS_______ S216
14-3-3 sigma (mouse) EAPEEPQS_______ S248